Out-Patient Commitment Order Use in Norway: Incidence and Prevalence

Total Page:16

File Type:pdf, Size:1020Kb

Out-Patient Commitment Order Use in Norway: Incidence and Prevalence BJPsych Open (2019) 5, e75, 1–7. doi: 10.1192/bjo.2019.60 Out-patient commitment order use in Norway: incidence and prevalence rates, duration and use of mental health services from the Norwegian Outpatient Commitment Study Henriette Riley, Ekaterina Sharashova, Jorun Rugkåsa, Olav Nyttingnes, Tore Buer Christensen, Ann-Torunn Andersen Austegard, Maria Løvsletten, Bjørn Lau and Georg Høyer Background 889). Use of in-patient care decreased significantly in the 3 years Norway authorised out-patient commitment in 1961, but there is after out-patient commitment compared with the 3 years before. a lack of representative and complete data on the use of out- Use of antipsychotic medication through the whole out-patient patient commitment orders. commitment period and fewer in-patient episodes in the 3 years before out-patient commitment predicted longer time to Aims readmission. To establish the incidence and prevalence rates on the use of out-patient commitment in Norway, and how these vary Conclusions across service areas. Further, to study variations in out- Mechanisms behind the pronounced variations in use of out- patient commitment across service areas, and use of patient commitment between sites call for further studies. Use of in-patient services before and after implementation of out- in-patient care was significantly reduced in the 3 years after a patient commitment orders. Finally, to identify determinants first-ever out-patient commitment order was made. for the duration of out-patient commitment orders and time to readmission. Declaration of interest None. Method Retrospective case register study based on medical files of all Keywords patients with an out-patient commitment order in 2008–2012 in six catchment areas in Norway, covering one-third of the Outpatient commitment; community treatment order; involun- Norwegian population aged 18 years or more. For a subsample of tary out-patient treatment. patients, we recorded use of in-patient care 3 years before and after their first-ever out-patient commitment. Copyright and usage © The Royal College of Psychiatrists 2019. This is an Open Access Results article, distributed under the terms of the Creative Commons Annual incidence varied between 20.7 and 28.4, and prevalence Attribution licence (http://creativecommons.org/licenses/by/ between 36.5 and 48.9, per 100 000 population aged 18 years or 4.0/), which permits unrestricted re-use, distribution, and above. Rates differed significantly between catchment areas. reproduction in any medium, provided the original work is Mean out-patient commitment duration was 727 days (s.d. = properly cited. The legal possibility of subjecting out-patients to mandatory care an increasing proportion of resources to community services in has steadily increased in recent decades, especially in North recent years. Further details about the Norwegian out-patient com- – America, Oceania and Europe.1 4 Norway authorised out-patient mitment population, the Norwegian out-patient commitment commitment as early as in 1961, when patients discharged with framework and what being on an out-patient commitment entailed an out-patient commitment order could be recalled to in-patient for patients is described in our previous paper from the Norwegian care without any further formalities. In 1999, the Norwegian Outpatient Commitment Study (NOCS).6 Mental Health Act was amended, authorising out-patient commit- Internationally, out-patient commitment has raised questions ment without a prior in-patient period. The coercive power of out- about the justification and effect of the order: does out-patient com- patient commitment orders in Norway is restricted to an obligation mitment reduce the overall use of coercion in the care of people with to comply with all scheduled treatment appointments, if necessary severe mental disorders, or does it increase coercion by adding coer- with the assistance of the police and the use of force. The legal cri- cive care in the community to in-patient coercion?7,8 Another fre- teria for out-patient commitment are the same as for in-patient quently raised question concerns the impact of out-patient commitment, including a requirement to make a global assessment commitment on the use of mental health services, especially in- – as to whether the intervention is the best option for the patient or patient care.4,9 11 Further, perceived coercion of patients with not. Out-patient commitment orders are valid for 1 year, but can out-patient commitment orders has received increased attention be renewed by an independent review board an unlimited number in recent years.12,13 The aim of NOCS was to collect representative of times. It is also noteworthy that the Norwegian Mental Health and complete data on the use of out-patient commitment in Act requires separate orders for involuntary placement and invol- Norway. In this paper, we report on population-based incidence untary treatment, for both in- and out-patients. Norway is among and prevalence rates, and changes in the utilisation of mental the countries with the highest number of mental health workers health care services before and after patients were subjected to per capita (240 per 100 000 population).5 The majority of these out-patient commitment, as well as predictors for the duration of are in out-patient services, and there has been a drive to allocate out-patient commitment orders and time to readmission. 1 Downloaded from https://www.cambridge.org/core. 01 Oct 2021 at 02:38:11, subject to the Cambridge Core terms of use. Riley et al such cases, we closely examined patients’ entire records, including Method relevant referral notes, discharge notes, nurses’ notes, reports from out-patient services, and correspondence between services, Study design including out-patient clinics. All data were meticulously checked NOCS is a retrospective case register study based on the examination to resolve potential discrepancies in the data-set and we held of medical files of all patients with an out-patient commitment order regular team meetings. between 2008 and 2012 in six Norwegian catchment areas. For the For the total sample, we recorded a limited number of variables: subsample of those who received their first-ever out-patient commit- demography, current out-patient commitment status, number and ment order in 2008 and 2009, we recorded the use of in-patient ser- duration of out-patient commitment episodes in 2008–2012, and vices 3 years before and after the out-patient commitment order. whether patients received an involuntary treatment order in con- junction with the out-patient commitment order or not. For those Settings with their first-ever out-patient commitment order in 2008 and The six study sites were located in different geographical areas across 2009 we recorded more comprehensive data (58 variables), includ- Norway. Sites were strategically selected in order to include both rural ing their consumption of in-patient care 3 years before and after the 6 first-ever out-patient commitment order. The in-patient’s admis- and urban populations. The areas are described elsewhere. The sites ’ were the University Hospital of North Norway, Helse Bergen Trust, sion resulting in the patient s first-ever out-patient commitment Sørlandet Hospital Trust, Innlandet Hospital Trust, Akershus was included in the number of in-patient-episodes 3 years before University Hospital and Lovisenberg Hospital. The latter two are out-patient commitment. Total numbers of involuntary in-patient located in the Oslo area, the capital. The total population in the com- placements each year from 2008 to 2013 were obtained through bined catchment areas equals one-third of the total Norwegian popu- routine annual reports at each participating site. lation aged 18 years or over, which was 3 867 645 in 2012. Statistical analyses Participants Incidence rates and point prevalence rates were calculated per 100 000 population (18 years of age or above) for each study year All patients aged 18 years or above who were on an out-patient com- from 2008 to 2012. Poisson regression was used to test for overall mitment order at the beginning of 2008 were included in the study. difference in incidence and point prevalence rates between sites. Further, we added all new out-patient commitment orders made To describe the sample and subsamples, we calculated means from 1 January 2008 to 31 December 2012. The total population (standard deviations) and medians (first and third quartiles) for in the combined catchment areas was 867 645 people (aged 18 continuous variables, while proportions were calculated for categor- years or above, 2012 figures). We identified a total of 1414 patients, ical variables. The Mann–Whitney U-test, Kruskal-Wallis H-test, representing 1700 out-patient commitment orders; of these, 274 Wilcoxon signed-ranks test and Pearson’s chi-squared test were patients received their first out-patient commitment in 2008 and used to compare groups when appropriate. 2009. Of all patients, 226 (16.0%) had two out-patient commitment Kaplan–Meier survival analysis with log-rank tests was per- episodes and 30 (2.1%) had three out-patient commitment episodes. formed to estimate crude associations between duration of the first- More than half of the patients (52.8%) were in the 30- to 50-year age ever out-patient commitment order and the following variables: group, with a slight predominance of men (56.4%). Diagnoses were site, gender, age, diagnosis, time since first contact with psychiatric only recorded for a subsample of 274 patients, and showed that services, use of psychiatric services before out-patient commitment, 76.9% were diagnosed within the schizophrenia disorders spectrum, living alone or not, involuntary admissions before first-ever out- 16.5% with affective mood disorders and 6.6% other diagnoses. patient commitment order, reference to danger to self or others, involuntary depot medication and follow-up variables. The same ana- Exclusion criteria lysis was performed for time to readmission.
Recommended publications
  • Annual Report 2020
    Annual Report Research Activity 2020 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................. 4 Division of Clinical Neuroscience .............................................................................................................. 4 Division of Clinical Neuroscience (NVR) Organizational Chart ................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma..................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders ........................................................................................................... 10 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy ................................................................................................................................... 11 Group Leader: Morten Lossisus Department of Neurosurgery Neurovascular-Cerebrospinal Fluid Research Group ............................................................................. 17 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................ 20 Group Leader: Eirik Helseth and Torstein Meling Vilhelm
    [Show full text]
  • Annual Report Research Activity 2019
    Annual Report Research Activity 2019 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................... 4 From Division Director Eva Bjørstad ........................................................................................................... 4 Division of Clinical Neuroscience (NVR) Organizational Chart ..................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma....................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders .............................................................................................................. 9 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy .................................................................................................................................... 11 Group Leader: Morten Lossius Department of Neurosurgery Neurovascular-Hydrocephalus Research Group ..................................................................................... 16 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................. 19 Group Leaders: Eirik Helseth and Torstein
    [Show full text]
  • Vascular Inflammation in Rheumatic And
    Vascular Inflammation in Rheumatic and Non- rheumatic Patients: A Controlled Study of Biopsy Specimens Obtained During Coronary Artery Surgery (Feiring Heart Biopsy Study) Doctoral thesis by Ivana Hollan Hospital for Rheumatic Diseases, Lillehammer, Norway The Feiring Heart Clinic, Feiring, Norway Rikshospitalet-Radiumhospitalet University Hospital, Oslo, Norway University of Oslo, Norway 2009 ISBN 978-82-8072-766-4 © Ivana Hollan, 2009 Series of dissertations submitted to the Faculty of Medicine, University of Oslo No. 779 ISBN 978-82- 8072-766-4 All rights reserved. No part of this publication may be reproduced or transmitted, in any form or by any means, without permission. Cover: Inger Sandved Anfinsen. Printed in Norway: AiT e-dit AS, Oslo, 2009. Produced in co-operation with Unipub AS. The thesis is produced by Unipub AS merely in connection with the thesis defence. Kindly direct all inquiries regarding the thesis to the copyright holder or the unit which grants the doctorate. Unipub AS is owned by The University Foundation for Student Life (SiO) 3 Imagination is more important than knowledge. For knowledge is limited to all we now know and understand, while imagination embraces the entire world, and all there ever will be to know and understand. Albert Einstein (1879-1955) 4 Content Acknowledgements 6 Abbreviations 8 List of papers 9 1. Introduction 10 1.1 Cardiovascular complications in inflammatory rheumatic diseases 10 1.1.1 Coronary artery disease in inflammatory rheumatic diseases 10 1.1.2 Cardiac involvement in spondyloarthritides 11 1.2 Causes of vascular lumen narrowing 11 1.2.1 Aortic and cardiac vasculitis 12 1.2.2 Diagnostic challenges in detecting aortic and cardiac vasculitis 13 1.3 Link between atherosclerosis and inflammation 14 1.4 Resistance to atherosclerosis in different vessels 16 1.5 The driving force behind the study 16 2.
    [Show full text]
  • Betydningen Av Komorbiditet, Kosten Og Medisiner
    PRESENTASJON AV PROSJEKTER I PARALLELLSESJONER 1* Tarmfloraen hos personer med sykelig overvekt; betydningen av komorbiditet, kosten og medisiner Per G. Farup1)2), Anne Stine Kvehaugen3), Martin Aasbrenn2)3) 1)Forskningsavdelingen, Sykehuset Innlandet HF, Brumunddal. 2)Enhet for anvendt klinisk forskning, Institutt for klinisk og molekylær medisin, Fakultet for medisin og helsefag, NTNU, Trondheim. 3)Kirurgisk avdeling, Sykehuset Innlandet HF, Gjøvik. Bakgrunn: En unormal tarmflora (fekal dysbiose) er vanlig hos personer med sykelig overvekt. Tarmfloraen regulerer energimetabolismen og fekal dysbiose kan være en årsak til både fedme og noe av den komorbiditet som er hyppig hos personer med sykelig overvekt. Mål/Hensikt: Studere forekomsten av fekal dysbiose og faktorer assosiert med fekal dysbiose hos personer med sykelig overvekt. Materiale og metode: Pasienter med BMI > 40 eller BMI > 35 kg/m2 med komplikasjoner ble vurdert for inklusjon. Bruk av medisiner ble notert, og kostholdet ble registrert med et validert matvarefrekvensskjema som inkluderte bruk av kunstige søtningsmidler (KS). En enhet KS ble definert som 100 ml drikke med KS eller to suketter. Fekal dysbiose ble målt med GA-map™ Dysbiosis Test (Genetic Analysis, Oslo, Norway) og angitt som Dysbiose Index (DI) skår 1-5, skår ≤2 er normalt. Resultatene er angitt som gjennomsnitt med SD, korrelasjoner og p-verdier. Resultater: Av totalt 350 fortløpende pasienter samtykket 159 til deltagelse og 104 leverte avføringsprøver (menn/kvinner: 18(17%)/86(83%); alder (SD): 44 (9) år). Dysbiose (DI skår > 2) ble påvist hos 67 (64%) pasienter. DI-skår:1-5 ble funnet hos henholdsvis 20 (19%), 18 (17%), 35 (34%), 14 (14%) and 17 (16%) pasienter.
    [Show full text]
  • Annual Report Research Activity 2018
    Annual Report Research Activity 2018 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo ................................................................................... 4 From Division Director Eva Bjørstad ........................................................................................................... 4 Division of Clinical Neuroscience (NVR) Organizational Chart ................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma ........................................................................................................................ 6 Group Leader: Nada Andelic Painful musculoskeletal disorders ............................................................................................................ 10 Group Leader: Cecilie Røe Department of Refractory Epilepsy – National Centre for Epilepsy Complex epilepsy ...................................................................................................................................... 11 Group Leader: Morten Lossius Department for Neurosurgery Neurovascular-Hydrocephalus Research Group .................................................................................... 15 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................ 18 Group Leader: Eirik Helseth and Torstein Meling
    [Show full text]
  • Gynaecology Healthcare Atlas 2015–2017 Helseatlas Hospital Referral Areas and Adjustment SKDE
    Gynaecology Healthcare Atlas 2015–2017 Helseatlas Hospital referral areas and adjustment SKDE The following fact sheets use the terms ‘hospital referral area’ and ‘adjusted for age’. These terms are explai- ned below. Aver. Hospital referral areas Inhabitants age Akershus 67% 201,911 47.2 The regional health authorities have a responsibility to provide satis- Vestre Viken 64% 196,644 48.6 Bergen 67% 178,531 46.7 factory specialist health services to the population in their catchment Innlandet 59% 166,569 50.3 area. In practice, it is the individual health trusts and private provi- Stavanger 70% 140,197 45.6 St. Olavs 66% 127,895 46.9 ders under a contract with a regional health authority that provide and Sørlandet 64% 120,307 47.8 Østfold 62% 119,927 49.2 perform the health services. Each health trust has a hospital referral OUS 72% 109,435 45.0 area that includes specific municipalities and city districts. Different Møre og Romsdal 61% 104,957 49.0 Vestfold 61% 95,564 49.3 disciplines can have different hospital referral areas, and for some ser- UNN 63% 77,413 48.2 Telemark 60% 71,665 49.8 vices, functions are divided between different health trusts and/or pri- Fonna 63% 70,749 48.2 vate providers. The Gynaecology Healthcare Atlas uses the hospital Hospital referral area Lovisenberg 84% 62,639 38.6 Diakonhjemmet 67% 59,811 46.3 referral areas for specialist health services for medical emergency ca- Nordland 61% 56,144 49.0 Nord-Trøndelag 61% 55,459 49.3 re.
    [Show full text]
  • Annual Report of Research Activity 2017
    Annual Report of Research Activity 2017 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and The University of Oslo ............................................................................................ 3 From Division Director Eva Bjørstad ..................................................................................................................... 3 Organizational Chart............................................................................................................................................. 4 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma .................................................................................................................................. 5 Group Leader: Nada Andelic Painful musculoskeletal disorders ........................................................................................................................ 8 Group Leader: Cecilie Røe Department of Refractory Epilepsy – National Centre for Epilepsy Complex epilepsy ............................................................................................................................................... 11 Group Leader: Morten I. Lossius Department for Neurosurgery Neurovascular‐Hydrocephalus Research Group ............................................................................................. 15 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ........................................................................................
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE Name: Thor Willy Ruud Hansen Date of birth: December 21, 1946 Place of birth: Fredrikstad, Norway Citizenship: Norwegian Address (Residence): Langmyrgrenda 45 B, N-0861 Oslo, Norway. Phone: 47-22237365; e-mail: [email protected] (Hospital) : Section on Neonatology, Department of Pediatrics, Rikshospitalet, N-0027 Oslo, Norway. Phone:47- 23074573. Fax: 47-23072960. University e-mail: [email protected] Hosp. e-mail: [email protected] Marital status: Married to Grethe Brynildsen, b.11.23.54 Children: Herdis Marie, b.10.29.87; Eirin, b.12.9.89; Erik Andreas, b.10.12.91. Languages: Norwegian/Scandinavian, English, Portuguese (fluent). Spanish, French, German (reasonable reading and some speaking ability). Italian (some reading). Education: Primary school: 1953-59 Skarmyra Skole, Moss 1959-60 Grefsen Skole, Oslo (summa cum laude) High School: 1960-64 Grefsen High School, Oslo 1964-65 Wauwatosa East High School, Wis., U.S.A. 1965-66 Grefsen High School, Oslo (summa cum laude) University: 1966-72 University of Oslo (cum laude) Degrees/exams/licenses: 1972 MD, University of Oslo, Faculty of Medicine 1972 ECFMG, Copenhagen 1975 Medical license, Norway 1977 DTM&H, University of Liverpool, School of Tropical Medicine and Hygiene. 1977 Medical license, Angola 1988 Dr.med. (Ph.D.), University of Oslo. 1991 Federation Licensing Exam (FLEX),USA. 1993 Medical license, Pennsylvania,USA 2003 Master of Health Administration, University of Oslo 1 Medical specialty: 1983 Pediatrics (Norway) 1990 Neonatology 1997 Certified in General Pediatrics by The American Board of Pediatrics (expired 12.31.2004) 1999 Certified in Neonatal/Perinatal Medicine by The American Board of Pediatrics (re-certified 2007- 2013) CLINICAL TRAINING/APPOINTMENTS TIME PLACE APPOINTMENT July 72-July 73 Modum Bads Psychiatric Resident (psychiatry) Clinic July 73-July 74 Telemark Central Hosp.
    [Show full text]
  • Gut Microbiota Alterations in Patients with Persistent Respiratory Dysfunction Three Months After Severe COVID-19
    medRxiv preprint doi: https://doi.org/10.1101/2021.07.13.21260412; this version posted July 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Gut microbiota alterations in patients with persistent respiratory dysfunction three months after severe COVID-19 Beate Vestad1,2, Thor Ueland1,3, Tøri Vigeland Lerum3,4, Tuva Børresdatter Dahl1,5, Kristian Holm1,2,3, 5,6 3,5 3,7 3,7 3,7 Andreas Barratt-Due , Trine Kåsine , Anne Ma Dyrhol-Riise , Birgitte Stiksrud , Kristian Tonby , Hedda Hoel1,3,8, Inge Christoffer Olsen9, Katerina Nezvalova Henriksen10,11, Anders Tveita12, Ravinea Manotheepan13, Mette Haugli14, Ragnhild Eiken15, Åse Berg16, Bente Halvorsen1,3, Tove Lekva1, Trine Ranheim1, Annika Elisabeth Michelsen1,3, Anders Benjamin Kildal17, Asgeir Johannessen3,18, Lars Thoresen19, Hilde Skudal20, Bård Reiakvam Kittang21, Roy Bjørkholt Olsen22, Carl Magnus Ystrøm23, 24 25 26 27 3,4 Nina Vibeche Skei , Raisa Hannula , Saad Aballi , Reidar Kvåle , Ole Henning Skjønsberg , Pål Aukrust1,3,29 , Johannes Roksund Hov1,2,3,28 and Marius Trøseid1,3,29 on behalf of the NOR-Solidarity study group 1Research Institute of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway 2Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway 3Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway 4 Department of Pulmonary Medicine, Oslo University Hospital Ullevål, 0424 Oslo, Norway 5Division of Critical Care and Emergencies, Oslo University Hospital, 0424 Oslo, Norway 6Division of laboratory Medicine, Dept.
    [Show full text]
  • Norske Abstracts Presentert I Stockholm
    Norske abstracts preseNtert i stockholm P425 : Asymptomatic arrhyth- Reduced RV and LV strains indicate subclini- cal cardiac dysfunction in asymptomatic ARVC mogenic right ventricular mutation carriers and that strain echocardiog- cardio myopathy mutation car- raphy may be helpful in decisions regarding riers have impaired biventri- preventive treatment. cular function by myocardial strain P431 : Type of fibrosis predicts serious events in patients K.H. Haugaa (Dept of Cardiology, Oslo with obstructive hypertrophic University Hospital, Rikshospitalet, Oslo / Norway), S.I. Sarvari (Dept of Cardiology, cardiomyopathy Oslo University Hospital, Rikshospitalet, Oslo V.M. Almaas (Dept. og Cardiology, Oslo Uni- /Norway), O.G. Anfinsen (Dept of Cardiology, versity Hospital, Rikshospitalet, University Oslo University Hospital, Rikshospitalet, Oslo of Oslo, Oslo /Norway), E. Heyerdahl Strom /Norway), T.P. Leren (Dept of Medical Gene- (Dept. of Pathology, Oslo University Hospi- tics, Oslo University Hospital, Rikshospitalet, tal, Rikshospitalet, Oslo /Norway), H. Scott Oslo /Norway), O.A. Smiseth (Dept of Cardio- (Dept. of Pathology, Oslo University Hospital, logy, Oslo University Hospital, Rikshospitalet, Rikshospitalet, Oslo /Norway), C.P. Dahl Oslo /Norway), J.P. Amlie (Dept of Cardiology, (Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo Oslo University Hospital, Rikshospitalet, Oslo /Norway), T. Edvardsen (Dept of Cardiology, /Norway), T. Edvardsen (Dept. of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo Oslo University Hospital, Rikshospitalet, Oslo /Norway) /Norway), S. Aakhus (Dept. of Cardiology, Purpose: Life threatening arrhythmias can occur Oslo University Hospital, Rikshospitalet, Oslo prior to apparent ventricular dysfunction in /Norway), O.R. Geiran (Dept. of Thoracic arrhythmogenic right ventricular cardiomyopathy and Cardiovascular Surgery, Oslo University (ARVC) mutation carriers. Myocardial strain by Hospital, Rikshospitalet, Oslo /Norway), J.P.
    [Show full text]
  • BMC Health Services Research Biomed Central
    BMC Health Services Research BioMed Central Research article Open Access The politics of local hospital reform: a case study of hospital reorganization following the 2002 Norwegian hospital reform Trond Tjerbo1,2 Address: 1Institute of Health Management and Health Economics, University of Oslo, Oslo, Norway and 2Norwegian Institute for Urban and Regional Affairs, Oslo, Norway Email: Trond Tjerbo - [email protected] Published: 20 November 2009 Received: 24 March 2009 Accepted: 20 November 2009 BMC Health Services Research 2009, 9:212 doi:10.1186/1472-6963-9-212 This article is available from: http://www.biomedcentral.com/1472-6963/9/212 © 2009 Tjerbo; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The Norwegian hospital reform of 2002 was an attempt to make restructuring of hospitals easier by removing politicians from the decision-making processes. To facilitate changes seen as necessary but politically difficult, the central state took over ownership of the hospitals and stripped the county politicians of what had been their main responsibility for decades. This meant that decisions regarding hospital structure and organization were now being taken by professional administrators and not by politically elected representatives. The question raised here is whether this has had any effect on the speed of restructuring of the hospital sector. Method: The empirical part is a case study of the restructuring process in Innlandet Hospital Trust (IHT), which was one of the largest enterprise established after the hospital reform and where the vision for restructuring was clearly set.
    [Show full text]
  • ECT Was First Used in Norway at Neevengården Hospital in Bergen, Nov
    ECT was first used in Norway at Neevengården hospital in Bergen, Nov. 1941 Norwegian official statistics: The activities of the mental asylums 1941 ECT was extensively used in Norway in the 1940s and 50s for example • Valen hospital, western Norway, first 7 months from June 8 1942: 83 patients in 7 months ≈ 60 per 100 000 Konrad Lunde 1943 • Psychiatric Clinic, University of Oslo, first 12 years from 1942: ≈ 7000 patients ≈ half of all patients Gabriel Langfeldt 1954; Einar Kringlen 2007 • Private psychiatric practitioner Torgeir Skabo, Skien, Telemark: ECT at office and sometimes in patients’ homes Kringlen 2007 ECT in Norway decreased in the 1960-70s, but was more than doubled 25 years later Turning point? Giacomo d’Elia to Haukeland Univ. Hospital, Bergen, Aug 1978 19781 20042 ECT-patients per 100 000 total population 10 24 Percentage of inpatients receiving ECT 2,8 5,3 1. Oddmund Volden & K Gunnar Götestam. [The use of electroconvulsive treatment in Norway during 1968-79]. Tidsskr Nor Laegeforen 1982;102: 411-2 2. Lindy Jarosch-von Schweder et al. Electroconvulsive therapy in Norway: rates of use, clinical characteristics, diagnoses, and attitude. J ECT 2011;27:292-5 Regional differences were marked in 2004 North Central West East South ECT-patients per 100 000 18 27 34 20 19 Lindy Jarosch-von Schweder et al. Electroconvulsive therapy in Norway: rates of use, clinical characteristics, diagnoses, and attitude. J ECT 2011;27:292-5 Frequency of ECT in Norway after 2004 No systematic nationwide study - 10-43/100 000? VG newspaper/Spets,
    [Show full text]